Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early therapeUtic RespOnse and Predictivity of Long-term Effectiveness of Upadacitinib in Ulcerative Colitis (EUROPE)

NCT05496348 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05496348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early therapeUtic RespOnse and Predictivity of Long-term Effectiveness of Upadacitinib in Ulcerative Colitis (EUROPE)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
October 20, 2022
Completion date
August 31, 2027
Enrollment
400 (estimated)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis